ZL-2201

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameZL-2201
Drug Alias NameZL-2201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-dependent protein kinase inhibitors
TargetsDNA-dependent protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZai Lab (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZai Lab (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A